DD3: A new prostate-specific gene, highly overexpressed in prostate cancer

Cancer Research

Volumn 59, Issue 23, 1999, Pages 5975-5979

  Bussemakers, Marion J G ^a   Van Bokhoven, Adrie ^a   Verhaegh, Gerald W ^a   Smit, Frank P ^a   Karthaus, Herbert F M ^b   Schalken, Jack A ^a   Debruyne, Frans M J ^a   Ru, Ning ^c   Isaacs, William B ^c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARCINOGENESIS; CHROMOSOME MAP; DNA DETERMINATION; GENE AMPLIFICATION; GENE MAPPING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOLECULAR BIOLOGY; POLYADENYLATION; PRIORITY JOURNAL; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; TISSUE SPECIFICITY;

BASE SEQUENCE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 9; EXONS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRONS; KARYOTYPING; MALE; MOLECULAR SEQUENCE DATA; PROSTATE; PROSTATIC NEOPLASMS; REFERENCE VALUES; RESTRICTION MAPPING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0033429470     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. Cancer statistics. CA. Cancer J. Clin., 47: 5-27, 1997.
2. Arcangeli, C. G., Ornstein, D. K., Keetch, D. W., and Andriole, G. L. Prostate-specific antigen as a screening test for prostate cancer: the United States experience. Urol. Clin. N. Am., 24: 299-306, 1997.
3. Bangma, C. H., Rietbergen, J. B., and Schröder, F. H. Prostate-specific antigen as a screening test: the Netherlands experience. Urol. Clin. N. Am., 24: 307-314, 1997.
4. Reissigl, A., and Bartsch, G. Prostate-specific antigen as a screening test: the Austrian experience. Urol. Clin. N. Am., 24: 315-321, 1997.
5. Rees, M. A., Resnick, M. I., and Oesterling, J. E. Use of prostate-specific antigen, Gleason score, and digital rectal examination in staging patients with newly diagnosed prostate cancer. Urol. Clin. N. Am., 24: 379-388, 1997.
6. Schalken, J. A. New perspectives in the treatment of prostate cancer. Eur. Urol., 31 (Suppl. 2): 20-23, 1997.
7. Auffray, C., and Rougeon, F. Purification of mouse immunoglobulin heavy chain messenger RNAs from total myeloma tumor RNA. Eur. J. Biochem., 107: 303-314, 1980.
8. Bussemakers, M. J. G., Van de Ven, W. J. M., Debruyne, F. M. J., and Schalken, J. A. Identification of high mobility group protein I(Y) as potential progression marker for prostate cancer by differential hybridization analysis. Cancer Res., 51: 606-611, 1991.
9. Gussow, D., Rein, R., Ginjaar, I., Hochstenbach, F., Seemann, G., Kottman, A., and Ploegh, H. L. The human β2-microglobulin gene: primary structure and definition of the transcriptional unit. J. Immunol., 139: 3132-3138, 1987.
10. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
11. Liang, P., and Pardee, A. B. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science (Washington DC), 257: 967-971, 1992.
12. Hakalahti, L., Vihko, P., Henttu, P., Autio-Harmainen, H., Soini, Y., and Vihko, R. Evaluation of PAP and PSA gene expression in prostatic hyperplasia and prostatic carcinoma using Northern blot analyses, in situ hybridization and immunohistochemical stainings with monoclonal and bispecific antibodies. Int. J. Cancer, 55: 590-597, 1993.
13. Uberbacher, E. C., and Mural, R. J. Locating protein-coding regions in human DNA sequences by a multiple sensor-neural network approach. Proc. Natl. Acad. Sci. USA, 88: 11262-11265, 1991.
14. Kozak, M. Interpreting cDNA sequences: some insights from studies on translation. Mamm. Genome, 7: 563-574, 1996.
15. Karr, J. F., Kantor, J. A., Hand, P., Eggensperger, D. L., and Schlom, J. The presence of the prostate-specific antigen-related genes in primates and the expression of recombinant human prostate-specific antigen in a transfected murine cell line. Cancer Res., 55: 2455-2462, 1995.
16. Sokoll, L. J., and Chan, D. W. Prostate-specific antigen: its discovery and biochemical characteristics. Urol. Clin. N. Am., 24: 253-259, 1997.
17. Israeli, R. S., Grob, M., and Fair, W. R. Prostate-specific membrane antigen and other prostatic tumor markers on the horizon. Urol. Clin. N. Am., 24: 439-450, 1997.
18. McCormack, R. T., Rittenhouse, H. G., Finlay, J. A., Sokoloff, R. L., Wang, T. J., Wolfert, R. L., Lilja, H., and Oesterling, J. E. Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era. Urology, 45: 729-744, 1995.
19. Reiter, R. E., Zhennen, G., Watabe, T., Thomas, G., Szigeti, K., Davis, E., Wahl, M., Nisitani, S., Yamashiro, J., Le Beau, M. M., Loda, M., and Witte, O. N. Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. Proc. Natl. Acad. Sci. USA. 95: 1735-1740, 1998.
20. Brannan, C. I., Dees, E. C., Ingram, R. S., and Tilghman, S. M. The product of the H19 gene may function as an RNA. Mol. Cell. Biol., 10: 28-36, 1990.
21. Brockdorff, N., Ashworth, A., Kay, G. F., McCabe, V. M., Norris, D. P., Cooper, P. J., Swift, S., and Rastan, S. The product of the mouse Xist gene is a 15 kb inactive X-specific transcript containing no conserved ORF and located in the nucleus. Cell, 71: 515-526, 1992.
22. Brown, C. J., Hendrich, B. D., Rupert, J. L., Lafreniere, R. G., Xing, Y., Lawrence, J., and Willard, H. F. The human XIST gene: analysis of a 17 kb inactive X-specific RNA that contains conserved repeats and is highly localized within the nucleus. Cell, 71: 527-542, 1992.
23. Askew, D. S., Li, J., and Ihle, J. N. Retroviral insertions in the murine His-1 locus activate the expression of a novel RNA that lacks an extensive open reading frame. Mol. Cell. Biol., 14: 1743-1751, 1994.
24. Velleca, M. A., Wallace, M. C., and Merlie, J, P. A novel synapse-associated noncoding RNA. Mol. Cell. Biol., 14: 7095-7104, 1994.
25. Tam, W , Ben-Yehuda, D., and Hayward, W. S. Bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNA. Mol. Cell. Biol., 17: 1490-1502, 1997.
26. Takeda, K., Ichijo, H., Fujii, M., Mochida, Y., Saitoh, M., Nishitoh, H., Sampath, T. K., and Miyazono, K. Identification of a novel bone morphogenetic protein-responsive gene that may function as a noncoding RNA. J. Biol. Chem., 273: 17079-17085, 1998.
27. Lanz, T. B., McKenna, N. J., Onate, S. A., Albrecht, U., Wong, J., Tsai, S. Y., Tsai, M-J., and O'Malley, B. W. A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell, 97: 17-27, 1999.
28. Li, J., Rhodes, J, C., and Askew, D. S. Evolutionary conservation of putative functional domains in the human homolog of the murine His-1 gene. Gene (Amst.), 184: 169-176, 1997.